Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
Fact Sheet - PDF Fact Sheet
2015 Annual Report on Form 10-K - PDF 2015 Annual Report on Form 10-K
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$12.06
Change (%) Stock is Down 0.01 (0.00%)
Volume1,518,163
Data as of 03/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
03/01/17OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement
BETHLEHEM, Pa., March 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that its OraQuick® HIV Self-Test has been designated as eligible for procurement by purchasing entities entitled to access Global Fund and/or UNITAID resources.  The OraQuick® HIV Self-Test has been classified by the Global Fund’s Expert Review Panel for Diagnostics as CATEGORY-2. The classification facilitates... 
Printer Friendly Version
02/27/17OraSure Technologies to Present at the Raymond James 38th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 27, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on March 6, 2017, at approximately 8:40... 
Printer Friendly Version
02/24/17OraSure Technologies Announces Director Retirement
BETHLEHEM, Pa., Feb. 24, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Roger L. Pringle will be retiring as a member of the Company’s Board of Directors, effective May 16, 2017.  Mr. Pringle is the Company’s longest tenured Director, having served on the Board since September 2000.  Prior to that, Mr. Pringle served as Chairman of the Board and Director of one of the Company’s ... 
Printer Friendly Version
02/08/17OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results
BETHLEHEM, Pa., Feb. 08, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2016. Financial HighlightsConsolidated net revenues for the fourth quarter of 2016 were $35.5 million, a 10% increase from the fourth quarter of 2015. Consolidated net revenues for the year ended December 31, 2016 rose to ... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/16/17 10:00 a.m. ET
OraSure Technologies, Inc. 2017 Annual Meeting of Stockholders
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet